These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15480415

  • 1. Protein kinase A isozyme switching: eliciting differential cAMP signaling and tumor reversion.
    Neary CL, Nesterova M, Cho YS, Cheadle C, Becker KG, Cho-Chung YS.
    Oncogene; 2004 Nov 18; 23(54):8847-56. PubMed ID: 15480415
    [Abstract] [Full Text] [Related]

  • 2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 18; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 18; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 4. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Ann N Y Acad Sci; 2005 Nov 18; 1058():255-64. PubMed ID: 16394142
    [Abstract] [Full Text] [Related]

  • 5. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4568-77. PubMed ID: 15240549
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines.
    Skålhegg BS, Johansen AK, Levy FO, Andersson KB, Aandahl EM, Blomhoff HK, Hansson V, Taskén K.
    J Cell Physiol; 1998 Oct 01; 177(1):85-93. PubMed ID: 9731748
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Extracellular catalytic subunit activity of the cAMP-dependent protein kinase in prostate cancer.
    Cvijic ME, Kita T, Shih W, DiPaola RS, Chin KV.
    Clin Cancer Res; 2000 Jun 01; 6(6):2309-17. PubMed ID: 10873081
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mapping intersubunit interactions of the regulatory subunit (RIalpha) in the type I holoenzyme of protein kinase A by amide hydrogen/deuterium exchange mass spectrometry (DXMS).
    Hamuro Y, Anand GS, Kim JS, Juliano C, Stranz DD, Taylor SS, Woods VL.
    J Mol Biol; 2004 Jul 23; 340(5):1185-96. PubMed ID: 15236976
    [Abstract] [Full Text] [Related]

  • 13. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Tortora G, Ciardiello F, Damiano V, Pepe S, Bianco C, di Isernia G, Davies SL, North P, Harris AL, Hickson ID.
    Clin Cancer Res; 1995 Jan 23; 1(1):49-56. PubMed ID: 9815886
    [Abstract] [Full Text] [Related]

  • 14. Novel, isotype-specific sensors for protein kinase A subunit interaction based on bioluminescence resonance energy transfer (BRET).
    Prinz A, Diskar M, Erlbruch A, Herberg FW.
    Cell Signal; 2006 Oct 23; 18(10):1616-25. PubMed ID: 16524697
    [Abstract] [Full Text] [Related]

  • 15. Differential localization of protein kinase A type II isozymes in the Golgi-centrosomal area.
    Keryer G, Skålhegg BS, Landmark BF, Hansson V, Jahnsen T, Taskén K.
    Exp Cell Res; 1999 May 25; 249(1):131-46. PubMed ID: 10328961
    [Abstract] [Full Text] [Related]

  • 16. Crystal structures of RIalpha subunit of cyclic adenosine 5'-monophosphate (cAMP)-dependent protein kinase complexed with (Rp)-adenosine 3',5'-cyclic monophosphothioate and (Sp)-adenosine 3',5'-cyclic monophosphothioate, the phosphothioate analogues of cAMP.
    Wu J, Jones JM, Nguyen-Huu X, Ten Eyck LF, Taylor SS.
    Biochemistry; 2004 Jun 01; 43(21):6620-9. PubMed ID: 15157095
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.